Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canal.
Suilane Coelho Ribeiro
No relevant relationships to disclose
Camila Motta Venchiarutti Moniz
No relevant relationships to disclose
Rachel Riechelmann
No relevant relationships to disclose
Giovanni Mendonca Bariani
No relevant relationships to disclose
Maria Ignez Braghiroli
No relevant relationships to disclose
Caio Nahas
No relevant relationships to disclose
Renata Coudry
No relevant relationships to disclose
Alexandra Khichfy Alex
No relevant relationships to disclose
Allyne Q. Carneiro
No relevant relationships to disclose
Daniela R. Nebuloni
No relevant relationships to disclose
Joao Glasberg
No relevant relationships to disclose
Paulo Hoff
No relevant relationships to disclose